A Phase 3 Trial Investigating Blinatumomab ( NSC# 765986) in Combination With Chemotherapy in Patients With Newly Diagnosed Standard Risk or Down Syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients With Localized B-Lymphoblastic Lymphoma (B-LLy)

Purpose

This phase III trial studies how well blinatumomab works in combination with chemotherapy in treating patients with newly diagnosed, standard risk B-lymphoblastic leukemia or B-lymphoblastic lymphoma with or without Down syndrome.

Eligibility

Ages: 1 to 31
Sexes: All
Accepts healthy volunteers?: No

For additional eligibility criteria, please contact the study team.

Contact the study team

Additional eligibility criteria and study procedure details can be explained by the study team. Please call or email:

William B. Slayton 
Phone: 352.273.8010
Email: cancer-center@ufl.edu

Gender

Male
Female

Keywords

Down syndrome, Lymphoma, Lymphoblastic leukemia, Lymphoblastic lymphoma

Principal Investigator

William Slayton, MD

Department

Oncology

Contact Information

cancer-center@ufl.edu

352.273.8010


Be an Informed Participant

Before deciding to participate in a research study, take time to learn about clinical research, how it's conducted and your rights as a research participant. Following are some helpful resources from independent sources. Always remember that a clinical research study is research, not treatment.

Know Who to Contact

  • Eligibility: For questions about a specific study and who is eligible to participate, call or email the contact person listed for that study.
  • Your Rights: For questions about your rights as a research participant, contact the UF Institutional Review Boards at 352-273-9600.
  • Feedback: For general questions or feedback about study listings, email the UF Clinical and Translational Science Institute at CTSI-Studies-L@lists.ufl.edu.

Other Resources

  • HealthStreet: Health-focused services, classes and events, and opportunities to participate in research.
  • ResearchMatch.org: Join a national registry of volunteers willing to be contacted about research studies.

For Research Teams